Your browser doesn't support javascript.
loading
The role of B cells in immune cell activation in polycystic ovary syndrome.
Ascani, Angelo; Torstensson, Sara; Risal, Sanjiv; Lu, Haojiang; Eriksson, Gustaw; Li, Congru; Teschl, Sabrina; Menezes, Joana; Sandor, Katalin; Ohlsson, Claes; Svensson, Camilla I; Karlsson, Mikael C I; Stradner, Martin Helmut; Obermayer-Pietsch, Barbara; Stener-Victorin, Elisabet.
Afiliación
  • Ascani A; Department of Internal Medicine, Medical University of Graz, Graz, Austria.
  • Torstensson S; Department of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden.
  • Risal S; Department of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden.
  • Lu H; Department of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden.
  • Eriksson G; Department of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden.
  • Li C; Department of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden.
  • Teschl S; Department of Internal Medicine, Medical University of Graz, Graz, Austria.
  • Menezes J; Department of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden.
  • Sandor K; Department of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden.
  • Ohlsson C; Centre for Bone and Arthritis Research, Department of Internal Medicine and Clinical Nutrition, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Svensson CI; Department of Drug Treatment, Sahlgrenska University Hospital, Region Västra Götaland, Gothenburg, Sweden.
  • Karlsson MCI; Department of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden.
  • Stradner MH; Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, Sweden.
  • Obermayer-Pietsch B; Department of Internal Medicine, Medical University of Graz, Graz, Austria.
  • Stener-Victorin E; Department of Internal Medicine, Medical University of Graz, Graz, Austria.
Elife ; 122023 07 04.
Article en En | MEDLINE | ID: mdl-37401759
Polycystic ovary syndrome is a lifelong condition associated with disrupted hormone levels, which affects around 15-20% of women. Characterised by increased levels of male sex hormones released by ovaries and adrenal glands, the condition affects menstrual cycles and can cause infertility and diabetes. Alongside the increase in male sex hormones, changes in the number of B cells have recently been observed in polycystic ovary syndrome. B cells produce antibodies that are important for fighting infection. However, it is thought that they might aggravate the condition by releasing antibodies and other inflammatory molecules which instead attack the body. It remained unclear whether changes in the B cell numbers were a result of excessive hormone levels or whether the B cells themselves were responsible for increasing the levels of male sex hormones. Ascani et al. showed that exposing female mice to excess male sex hormones leads to symptoms of polycystic ovary syndrome and causes the same changes to B cell frequencies as observed in women. This effect was prevented by simultaneously treating mice with a drug that blocks the action of male sex hormones. On the other hand, transferring antibodies from women with polycystic ovary syndrome to mice led to greater body weight and variation in B cell numbers. However, it did not result in clear symptoms of polycystic ovary syndrome. Furthermore, mice without B cells still developed symptoms when exposed to male sex hormones, showing that B cells alone are not solely responsible for the development of the condition. Taken together, the experiments show that B cells are not central mediators of polycystic ovary syndrome and the variation in their numbers is due to excess male sex hormones. This raises the question of whether B cells are an appropriate target for the treatment of this complex condition and paves the way for studies on how other immune cells are altered by hormones. Future work should also investigate how B cell function affects symptoms associated with polycystic ovary syndrome, given the association between antibody transfer and weight gain in mice.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Síndrome del Ovario Poliquístico Límite: Animals / Female / Humans Idioma: En Revista: Elife Año: 2023 Tipo del documento: Article País de afiliación: Austria

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Síndrome del Ovario Poliquístico Límite: Animals / Female / Humans Idioma: En Revista: Elife Año: 2023 Tipo del documento: Article País de afiliación: Austria